Qu’en est-il de l ’application des nano vecteurs lipidiques à la maladie de Parkinson ?

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2017Publisher:University Oran 1, Ahmed BENBELLA, AlgeriaJournal:Journal de la faculté de médecine d'Oran (issn: 2571-9874, eissn: 2602-6511,

Copyright policy )

Authors: Sihem BOULENOUAR; Nassima MOUSSAOUI;

doi: 10.51782/jfmo.v4i2.113

Qu’en est-il de l ’application des nano vecteurs lipidiques à la maladie de Parkinson ?

- Summary
- Metrics

Abstract

Nombreux sont les travaux consacrés au développement des thérapies innovantes pour le traitement de la maladie de Parkinson. L’encapsulation de la dopamine, de la L-DOPA ou des agonistes dopaminergiques dans des nano-vecteurs lipidiques vise à pallier les diverses limites rencontrées lors de l’administration de ces substances sous forme libre. Cet article illustre les avancées récentes dans ce domaine.

Related Organizations

University of Oran
Algeria

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

Found an issue? Give us feedback

0

Average

gold